FR3529M - Nouveau dérivé de l'acide anthranilique utilisable en thérapeutique, notamment comme agent anti-inflammatoire. - Google Patents

Nouveau dérivé de l'acide anthranilique utilisable en thérapeutique, notamment comme agent anti-inflammatoire.

Info

Publication number
FR3529M
FR3529M FR985808A FR985808A FR3529M FR 3529 M FR3529 M FR 3529M FR 985808 A FR985808 A FR 985808A FR 985808 A FR985808 A FR 985808A FR 3529 M FR3529 M FR 3529M
Authority
FR
France
Prior art keywords
therapy
inflammatory agent
anthranilic acid
new derivative
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR985808A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH702763A external-priority patent/CH439319A/de
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR3529M publication Critical patent/FR3529M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • C07C273/1854—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas by reactions not involving the formation of the N-C(O)-N- moiety

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR985808A 1963-06-05 1964-08-21 Nouveau dérivé de l'acide anthranilique utilisable en thérapeutique, notamment comme agent anti-inflammatoire. Expired FR3529M (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH702763A CH439319A (de) 1963-06-05 1963-06-05 Verfahren zur Herstellung von N,N-aliphatisch disubstituierten 5-Dialkylsulfamyl-anthranil-säureamiden
CH419664 1964-04-02
CH590064 1964-05-06
FR976292A FR1403935A (fr) 1963-06-05 1964-05-29 Nouveaux amides d'acides anthraniliques

Publications (1)

Publication Number Publication Date
FR3529M true FR3529M (fr) 1965-09-06

Family

ID=27174751

Family Applications (3)

Application Number Title Priority Date Filing Date
FR976292A Expired FR1403935A (fr) 1963-06-05 1964-05-29 Nouveaux amides d'acides anthraniliques
FR985807A Expired FR3528M (fr) 1963-06-05 1964-08-21 Nouveaux dérivés de l'acide anthranilique, utilisables en thérapeutique, notamment comme agents anti-inflammatoires et hypotenseurs.
FR985808A Expired FR3529M (fr) 1963-06-05 1964-08-21 Nouveau dérivé de l'acide anthranilique utilisable en thérapeutique, notamment comme agent anti-inflammatoire.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
FR976292A Expired FR1403935A (fr) 1963-06-05 1964-05-29 Nouveaux amides d'acides anthraniliques
FR985807A Expired FR3528M (fr) 1963-06-05 1964-08-21 Nouveaux dérivés de l'acide anthranilique, utilisables en thérapeutique, notamment comme agents anti-inflammatoires et hypotenseurs.

Country Status (11)

Country Link
US (1) US3318882A (fr)
AT (3) AT254176B (fr)
BE (1) BE648829A (fr)
BR (1) BR6459789D0 (fr)
DE (1) DE1445629B1 (fr)
ES (1) ES300569A1 (fr)
FR (3) FR1403935A (fr)
GB (1) GB1033268A (fr)
MY (1) MY6900400A (fr)
NL (1) NL140236B (fr)
SE (3) SE311644B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL104059C (fr) * 1955-05-03
US3624202A (en) * 1969-01-22 1971-11-30 Roland Jaques Process for stilling pain
US3678052A (en) * 1970-06-11 1972-07-18 Squibb & Sons Inc Benzamide derivatives
CH590262A5 (fr) * 1973-07-10 1977-07-29 Ciba Geigy Ag
DE2611705A1 (de) * 1976-03-18 1977-09-22 Josef Dipl Chem Dr Rer N Klosa N-5-(nitrofurfuryliden-)-1-amino- hydantoin enthaltende kristalloesungsmittel
CH627446A5 (fr) * 1978-01-17 1982-01-15 Debiopharm Sa Nouveaux derives de la benzamide.
CY1344A (en) * 1978-08-10 1987-01-16 Ciba Geigy Ag Substituted anthranilic acid amides,process for their preparation,and pharmaceutical compositions containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB882090A (en) * 1958-03-04 1961-11-08 Geigy Ag J R New sulphamoyl benzamides and processes for the production thereof
US3072656A (en) * 1960-01-22 1963-01-08 Ciba Geigy Corp 2-cycloaliphatic-6-sulfamyl-7-halo(or trihalomethyl)-1, 2, 3, 4-tetrahydro-4-quinazolones

Also Published As

Publication number Publication date
DE1445629B1 (de) 1971-08-12
AT254176B (de) 1967-05-10
MY6900400A (en) 1969-12-31
FR3528M (fr) 1965-09-06
BE648829A (fr) 1964-12-04
SE311517B (fr) 1969-06-16
GB1033268A (en) 1966-06-22
SE311646B (fr) 1969-06-23
NL6406335A (fr) 1964-12-07
BR6459789D0 (pt) 1973-07-17
US3318882A (en) 1967-05-09
ES300569A1 (es) 1964-11-16
AT254221B (de) 1967-05-10
NL140236B (nl) 1973-11-15
FR1403935A (fr) 1965-06-25
SE311644B (fr) 1969-06-23
AT261593B (de) 1968-05-10

Similar Documents

Publication Publication Date Title
FR3528M (fr) Nouveaux dérivés de l'acide anthranilique, utilisables en thérapeutique, notamment comme agents anti-inflammatoires et hypotenseurs.
FR3439M (fr) Nouvelle quinazoline utilisable en thérapeutique, notamment comme analgésique.
FR3639M (fr) Nouvelle protéine utilisable en thérapeutique, notamment comme agent pour le traitement de tumeurs solides.
FR3784M (fr) Dérivés de l'acide phénylacétique.
FR2599M (fr) Nouveau dérivé de l'acide anthranilique utilisable en thérapeutique, notamment comme agent anti-inflammatoire.
FR3513M (fr) Nouveuax dérivés d'esters d'alpha-aminoacides n-substitués.
FR2598M (fr) Nouveaux dérivés de l'acide anthrauilique, utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR3397M (fr) Amides de l'acide isoindolinyl-2-acétique.
FR3308M (fr) Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR3791M (fr) Nouvel ester de la δ<4>-7-α-méthyl-4,17β-dihydroxy-19-nor-androstene-3-one et de l'acide phénylpropionique utilisable en thérapie.
FI46955C (fi) Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-alempi-al kyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi
FR3534M (fr) Nouvelle isoquinoléine utilisable en thérapeutique, notamment comme agent antitussif.
FR2819M (fr) Nouveau dérivé rapidement soluble de l'acide acéthylsalicylique.
FI43992C (fi) Valmistusmenetelmä uusille terapeuttisesti käytettäville 1-dialkyyliaminoalkyyli-4-okso-1,2,3,4-tetrahydrokinatsoliineille sekä niiden happoadditiosuoloille
FR3305M (fr) Trinicotinoylglycérine et ses sels d'addition d'acides, utiles comme agents vasodilatateurs.
FI43185C (fi) Menetelmä terapeuttisesti vaikuttavien 3,4-diklooribentseenisulfonihappo-3,4-substituoitu-anilidien valmistamiseksi
FR3728M (fr) Nouveaux dérivés de substitution de l'acide acétique utilisables en thérapeutique.
FI36795A (fi) Menetelmä N-(2,3-dimetyylifenyyli)-antraniilihapon valmistamiseksi
FI36794A (fi) Menetelmä N-(2,3-dimetyylifenyyli)-antraniilihapon valmistamiseksi
FI36695A (fi) Menetelmä N-(2,3-dimetyylifenyyli)-antraniilihapon valmistamiseksi
FI36694A (fi) Menetelmä N-(2,3-dimetyylifenyyli)-antraniilihapon valmistamiseksi
FI36696A (fi) Menetelmä N-(2,3-dimetyylifenyyli)-antraniilihapon valmistamiseksi
FI36697A (fi) Menetelmä N-(2,3-dimetyylifenyyli)-antraniilihapon valmistamiseksi
FI36793A (fi) Menetelmä N-(2,3-dimetyylifenyyli)-antraniilihapon valmistamiseksi
FI36698A (fi) Menetelmä N-(2,3-dimetyylifenyyli)-antraniilihapon valmistamiseksi